{
 "PrintNo":"S7753","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-11-15T09:24:00.610221Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO RULES","Date":"2023-11-15","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[
  {"ID":1492,"Name":"Mario Mattera","Short":"MATTERA"},
  {"ID":1512,"Name":"Jessica Scarcella-Spanton","Short":"SCARCELLA-SPANTON"}
 ],
 "Title":"Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine",
 "Summary":"Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.",
 "LawSection":"Public Health Law",
 "LawCode":"Amd §3306, Pub Health L; amd §§220.00, 220.43, 220.41, 220.39, 220.21, 220.18, 220.16 & 220.09, Pen L",
 "ActClause":"AN ACT to amend the public health law, in relation to the classification of the drug xylazine as a controlled substance; and to amend the penal law, in relation to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine",
 "SameAsPrintNo":"A8130-2023"
}